13 Stocks Moving In Wednesday's After-Hours Session

Gainers

• Sonos (NASDAQ:SONO) shares are trading higher after the company reported better-than-expected Q3 EPS and sales results.
• Opendoor Technologies (NASDAQ:OPEN) shares are trading higher after the company reported better-than-expected Q2 EPS and sales results.
• Hims & Hers Health (NYSE:HIMS) shares are trading higher after the company reported better-than-expected Q2 EPS and sales results and issued Q3 2021 revenue guidance above estimates.
• Clover Health Investments (NASDAQ:CLOV) shares are trading higher after the company reported better-than-expected Q2 sales results and issued FY21 sales guidance above estimates.
• Alpha & Omega Semiconductor (NASDAQ:AOSL) shares are trading higher after the company reported better-than-expected Q4 EPS and sales results and issued Q1 sales guidance above estimates.
• Fossil Group (NASDAQ:FOSL) shares are trading higher after the company reported Q2 adjusted EPS results were higher year over year and better-than-expected Q2 sales results. The company also raised guidance.
• Root (NASDAQ:ROOT) shares are trading higher after the company, and Carvana, announced an exclusive partnership to develop integrated auto insurance solutions for Carvana's online car buying platform. Carvana will invest approximately $126 million in Root.
• Conifer (NASDAQ:CNFR) shares are trading higher after the company reported better-than-expected Q2 sales results.

Losers

• Fisker (NYSE:FSR) shares are trading lower after the company reported a $600 million green convertible notes offering.
• LifeStance Health (NASDAQ:LFST) shares are trading lower after the company reported Q2 earnings results.
• Matterport (NASDAQ:MTTR) shares are trading lower after the company reported Q2 EPS results were down year over year.
• AudioEye (NASDAQ:AEYE) shares are trading lower after the company reported worse-than-expected Q2 sales results and issued Q3 sales guidance below estimates.
• Coupang (NYSE:CPNG) shares are trading lower after the company reported worse-than-expected Q2 EPS and sales results.